Search results
Apple has ‘very serious’ non-compliance issues with key EU digital law, Margrethe Vestager says
NY Post via Yahoo News· 14 hours ago“We have a number of Apple issues. I find them very serious. I was very surprised that we would have...
Apple Holding Off on Vision Pro 2 in Favor of Cheaper Model: Report - Decrypt
Decrypt· 5 hours agoApple is putting the next generation of its $3,500 Apple Vision Pro headset on the back-burner as it...
Apple faces serious issues under new EU tech rules, says Margrethe Vestager | Invezz
Invezz· 22 hours agoThis legislation, aimed at regulating Big Tech companies, has put Apple under scrutiny for...
EU has very serious issues with Apple, says competition chief - iOS Discussions on AppleInsider...
AppleInsider· 16 hours agoAntitrust executive Margrethe Vestager says the EU has multiple issues over Apple's App Store and...
Apple Has 'Very Serious' DMA Issues, EU to Enforce Rules 'Soon'
MacRumors· 11 hours agoApple is facing a "number" of "very serious" issues with its Digital Markets Act compliance in...
Apple has 'very serious' issues under EU's sweeping Digital Markets Act - Vestager
MacDailyNews· 12 hours agoApple has numerous “very serious” issues under the European Union’s sweeping Digital Markets Act,...
Gateway - Quartz
Quartz· 12 hours agoOverall shipments of non-Chinese smartphones climbed to 3.75 million units year-over-year. Apple has been struggling to compete with rivals like Huawei ...
Apple Watch Ultra 3: What we know so far
Pocket-lint· 15 hours agoThe Ultra series has proven a popular addition to the Apple Watch lineup, and understandably -- even if you're not the hardcore fitness or adventure fan ...
Dow Jones Futures: New Stock Market King Nvidia Faces This Risk; ELF, Palantir Rally
Investor's Business Daily· 4 hours agoWhat To Do In The Stock Market Today The stock market rally continues to act well. A Nasdaq pause...
Apple downgraded, Kroger upgraded: Wall Street's top analyst calls
The Fly via Yahoo Finance· 17 hours agoAlliance Global Partners initiated coverage of Chromocell Therapeutics (CHRO) with a Buy rating and...